GEN - Genetic Engineering and Biotechnology News4d
Mount Sinai Launches AI Small Molecule Drug Discovery Center
The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...
Business Wire28d
Arrakis Therapeutics Announces Oral Presentation Describing RNA-targeted Small Molecule to Treat Myotonic Dystrophy at MDA Conference 2025
Details of the presentation are as follows: Arrakis’s DM1 drug program represents a rationally designed small molecule genetic medicine directed at a pathogenic RNA to achieve reversal of ...
Small molecules, big role: Interactive database illustrates how snoRNAs function in gene regulation
Small nucleolar RNAs (snoRNAs) are non-coding RNA molecules whose role in gene regulation and association with certain ...
BioPharma Dive11d
Epicrispr banks $68M to test epigenetic editing on rare muscle disease
The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a ...
Yahoo Finance19d
Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
Ramat Gan, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs ...
News-Medical.Net on MSN4d
Mount Sinai launches AI center to revolutionize small molecule drug discovery
The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.